Obagi Medical

Search:
Home

HISTORY

NEWS AND PR
In The Media
Press Releases
Clinical & Prof. Publications

CAREERS

CONTACT US

TERMS AND CONDITIONS

INVESTOR RELATIONS


For PatientsFor PhysiciansFor Skin Care SpecialistsAbout Obagi Medical


OBAGI MEDICAL PRODUCTS APPOINTS
RICHARD J. KOZLOSKIEXECUTIVE DIRECTOR OF
NEW THERAPEUTIC DERMATOLOGY DIVISION

LONG BEACH, Calif., July 25, 2006– Obagi Medical Products, Inc. (Obagi), the market leader in specialty skin health systems, announced today that Rick Kozloski has agreed to join the company as Executive Director, Therapeutic Dermatology Division, reporting to President and CEO, Steve Carlson. In this role, Mr. Kozloski will provide strategic direction for the execution of Obagi’s expansive development programs, focused on strengthening the company’s position in treating major skin diseases and disorders.

“Mr. Kozloski brings years of insight and a wealth of knowledge in the dermatology and medical aesthetics markets” said Carlson. “His skills are well suited to creating and executing new strategies and opportunities that support our Penetrating Therapeutics™ technologies with science based clinical studies.”

“Obagi has reached a critical point in its evolution and I am excited by the opportunity of guiding the introduction of a rich pipeline of therapeutically unique products to the dermatology world” said Kozloski. “Just as importantly, I will be working with a dedicated, creative, and experienced management team at a pivotal time in the company’s history.”

Mr. Kozloski joins Obagi with over 15 years of experience at Allergan, Inc. (NYSE: AGN), where he held a variety of sales, marketing and strategic management positions. During his tenure at Allergan, he developed highly successful strategic marketing campaigns for Allergan’s dermatology and medical aesthetics products including BOTOX® and Tazorac®. Mr. Kozloski received his BS in Finance and Economics from Pennsylvania State University.

About Obagi Medical Products, Inc.
Obagi develops and commercializes skin health products for the dermatology, plastic surgery and related Aesthetic markets. Using its Penetrating Therapeutics™ technologies, Obagi’s products are designed to improve penetration of agents across the skin barrier for common skin disorders in adult skin such as chloasma, melasma, senile letigines, acne vulgaris and sun damage. Obagi launched its first skincare system, Obagi-Nu-Derm System, in 1988; and in 2004 launched the first and only prescription strength Vitamin C and hydroquinone system, Obagi-C Rx System. Obagi System products are only available through physicians, primarily Dermatologists and Plastic Surgeons, Medical Spas and other Skin Care Specialists. For more information please visit www.obagi.com.